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C erebral venous thrombosis (CVT) is a cerebrovascular disease that often affects young-and middle-aged patients resulting in substantial disability and death. 1, 2 Patients with CVT present with nonspecific neurological complaints, including headache and seizure. 3, 4 The annual incidence of CVT may be as high as 15.7 cases per million persons, 2 but many physicians encounter CVT infrequently. As a consequence, diagnosing CVT in the emergency setting can be challenging. 5 We, therefore, sought to determine the rate of CVT misdiagnosis and explore whether misdiagnosis of CVT is associated with adverse clinical outcomes in a large, heterogeneous cohort.
Methods
The data and analytic methods of this study are available on request from the corresponding author.
Design
We performed a retrospective cohort study of patients with CVT using publically available data collected by the Agency for Healthcare Research and Quality, extracted from claims from New York, California, and Florida (Methods in the online-only Data Supplement). The institutional review board at Weill Cornell Medicine approved this component of the study.
Patients
We included all hospitalized adult patients with a first-recorded discharge diagnosis of CVT. CVT was defined using previously validated International Classification of Diseases, Ninth Revision, Clinical Modification codes (Methods in the online-only Data Supplement).
Measurements
The primary study outcome was probable misdiagnosis of CVT (Methods in the online-only Data Supplement), defined as an emergency department (ED) visit for headache or seizure in the 14 days before CVT hospitalization that did not result in an admission or transfer to another hospital (ie, ED treat-and-release visit). The time frame of 14 days was chosen to ensure that the ED visit was plausibly related to the subsequent hospitalization for CVT. ED visits for headache or seizure were used as these are common symptoms of CVT. To explore temporal trends of CVT hospitalization after ED discharge, we identified ED visits for back pain within 14 days before CVT hospitalization. Back pain is not a known early symptom of CVT and thus served as a negative control comparator.
We identified the following risk factors for CVT at index hospitalization: traumatic brain injury, primary hypercoagulable state, polycethermia vera, any cancer, pregnancy and the puerperium, and central nervous system infections (Methods in the online-only Data Supplement). 6 We used the Elixhauser comorbidity index to account for disease severity. 7 To assess whether probable misdiagnosis of CVT was associated with adverse clinical outcomes, we evaluated rates of intracerebral hemorrhage, in-hospital death, and unfavorable discharge disposition. We defined unfavorable discharge disposition as discharge to a skilled nursing facility, subacute care center, chronic rehabilitation center, or hospice as opposed to discharge to home. Finally, in an exploratory analysis, we evaluated whether history of a primary headache disorder was associated with probable CVT misdiagnosis (Methods in the online-only Data Supplement).
Confirmatory Cohort Analysis
We performed a confirmatory cohort analysis via chart review of adult patients with CVT hospitalized at Weill Cornell Medicine and Montefiore Medical Center after obtaining approval from both institutional review boards. We included all available cases of CVT at Weill Cornell Medicine from January 1, 2007 to January 1, 2015 and at Montefiore Medical Center from September 1, 2005 to September 1, 2015. Probable CVT misdiagnosis was defined as in our claims analysis. Modified Rankin Scale at hospital discharge was abstracted for all patients; Modified Rankin Scale >1 was defined as unfavorable.
Statistical Analysis
Descriptive statistics with exact confidence intervals (CIs) were used to calculate crude rates of probable CVT misdiagnosis. Comparisons between groups were performed using the t test for continuous variables and χ 2 test for categorical variables. Variance-weighted least squares regression was used to compare patterns of headache or seizure versus back pain ED treat-and-release visits. Multivariable logistic regression was used to evaluate whether probable CVT misdiagnosis was associated with intracerebral hemorrhage, death, increased length of stay, and unfavorable discharge disposition. Statistical significance was set at α=0.05.
Results
We identified 5966 patients with CVT, among whom the mean age was 44.2±18.4 years; 4276 (71.7%) were women. A total of 216 (3.6%; 95% CI, 1.1%-4.1%) cases had an ED treat-and-release visit 14 days before CVT hospitalization for headache or seizure (ie, probable CVT misdiagnosis). Patients with a probable CVT misdiagnosis were younger (38.5 versus 44.4 years) and more likely have a primary hypercoagulable state (Table I in the online-only Data Supplement). Thirteen patients (0.2%; 95% CI, 0.1%-0.4%) had an ED treat-and-release visit for back pain within 14 days before CVT hospitalization.
Among patients with a probable CVT misdiagnosis, headache was more common (96.8%) than seizure (3.2%; P<0.001).
Rates of ED visits where headache or seizure were diagnosed steadily increased from 14 days before CVT to 1 day before CVT hospitalization (0.08% versus 0.49%; P=0.02; Figure) . Rates of ED visits for back pain were unchanged from 14 days before CVT to 1 day before CVT hospitalization (0.01% versus 0.05%; P=0.2). History of primary headache disorder was not associated with probable CVT misdiagnosis (19.0% misdiagnosed versus 14.9% nonmisdiagnosed; P=0.1).
When we adjusted for demographics, risk factors, and the Elixhauser comorbidity index, a probable misdiagnosis of CVT was neither associated with intracerebral hemorrhage (odds ratio, 0.97; 95% CI, 0.57-1.65), in-hospital mortality (odds ratio, 0.14; 95% CI, 0.02-1.05), or unfavorable discharge outcome (odds ratio, 0.90; 95% CI, 0.61-1.32). A longer length of hospital stay was seen in misdiagnosed patients (odds ratio, 1.62; 95% CI, 1.04-2.50; Table II in the onlineonly Data Supplement).
We identified a total of 134 patients with CVT in the confirmatory cohort. Within the 14 days before CVT hospitalization, a total of 8 patients (6.0%; 95% CI, 2.6%-11.4%) had an ED treat-and-release visit for headache; no patients had an ED visit for seizure. Probable misdiagnosis of CVT was not associated with an unfavorable discharge modified Rankin Scale (3/8 [37.5%] misdiagnosed versus 51/126 [40.5%] nonmisdiagnosed; P=0.9).
Discussion
In a large, heterogeneous cohort, we found that ≈1 in 30 patients with CVT were initially misdiagnosed. We did not find an association between probable misdiagnosis and any studied adverse outcomes aside from increased length of stay. In our smaller confirmatory cohort, ≈1 in 18 patients were misdiagnosed and these patients had similar outcomes compared with patients without a CVT misdiagnosis.
Similar rates of CVT misdiagnosis in our study and confirmatory cohorts support our measurement technique. However, we acknowledge that we may have underestimated the rate of CVT misdiagnosis because we did not capture patients who did not return for medical evaluation after an ED visit, those who were not diagnosed with CVT when they did return, or those who died before an accurate diagnosis could be made. Alternatively, we may have overestimated rates of CVT misdiagnosis because some ED treat-and-release visits for seizure or headache may have been unrelated to subsequent CVT. However, this latter possibility seems less likely given the temporal relationship we found between ED treat-and-release visits for seizure or headache and subsequent CVT hospitalization.
Our finding of no differences in major clinical outcomes between patients with a probable CVT misdiagnosis versus those without a misdiagnosis is largely consistent with prior work. In the International Study on Cerebral Vein and Dural Sinus Thrombosis, there were no significant differences in the delayed versus nondelayed diagnosis groups except among CVT patients with isolated increased intracranial hypertension. 8, 9 Given the increasingly recognized impact of CVT on long-term cognition and employment status, 10 more granular outcome data than that used in our study, including visual field, visual acuity, and cognitive measurements, are needed to further quantify the clinical effects of misdiagnosis.
This study has several limitations. First, data on presenting headache semiology and physical examination findings are lacking. In addition, because we relied exclusively on ED visits for seizure or headache to define probable CVT misdiagnosis, we failed to account for ED visits where misdiagnosis may have occurred because of alternative early manifestations of CVT, such as isolated visual complaints. Second, misdiagnosis of CVT was limited to patients who were seen in the ED and not initially hospitalized. Third, we were unable to adjust for important CVT risk factors, such as use of hormonal therapy, which are unavailable in administrative claims data. Fourth, our outcomes were limited to in-hospital measurements, and thus we were unable to evaluate long-term functional status. Finally, we lack hospital-level (eg, academic or community), provider-level (eg, ED physician practice experience), and detailed encounterlevel (eg, was neurological consultation obtained, what imaging studies were performed) data, as well as information about the extent of inpatient diagnostic evaluations in this study.
In summary, we identified CVT misdiagnosis in a small but nontrivial percentage of patients with CVT using a large, heterogeneous multistate cohort.
